Development of a technology for the clinical treatment of cancer, including:
• Creation of a new generation source of epithermal neutrons suitable for clinical use, conduct of clinical trials required to obtain medical license from the Ministry of Health on the use of the Boron Neutron Capture Therapy of malignant tumors;
• Development of a national synthesis technology already used (borfenilalanin) and of promising boron-containing drugs for BNCT in order to realize import substitution and increase the efficiency of treatment;
• Creation of a NSU clinic for the implementation of a BNCT pilot-project in Russia. The project has a designed capacity of 500 patients a year.
• Training of medical workers and physicists for the implementation of Bore Neutron Capture Therapy.